Henry O Gosebruch - Net Worth and Insider Trading

Henry O Gosebruch Net Worth

The estimated net worth of Henry O Gosebruch is at least $23 Million dollars as of 2024-11-13. Henry O Gosebruch is the EVP, Chief Strategy Officer of AbbVie Inc and owns about 98,580 shares of AbbVie Inc (ABBV) stock worth over $17 Million. Henry O Gosebruch is the President & CEO of Neumora Therapeutics Inc and owns about 524,793 shares of Neumora Therapeutics Inc (NMRA) stock worth over $6 Million. Henry O Gosebruch is also the Director of Acelyrin Inc and owns about 50,000 shares of Acelyrin Inc (SLRN) stock worth over $294,000. Besides these, Henry O Gosebruch also holds Aptinyx Inc (APTX) . Details can be seen in Henry O Gosebruch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry O Gosebruch has not made any transactions after 2023-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Henry O Gosebruch

To

Henry O Gosebruch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Henry O Gosebruch owns 4 companies in total, including Aptinyx Inc (APTX) , AbbVie Inc (ABBV) , and Acelyrin Inc (SLRN) among others .

Click here to see the complete history of Henry O Gosebruch’s form 4 insider trades.

Insider Ownership Summary of Henry O Gosebruch

Ticker Comapny Transaction Date Type of Owner
APTX Aptinyx Inc 2020-01-10 director
ABBV AbbVie Inc 2022-05-16 Chief Strategy Officer
SLRN Acelyrin Inc 2023-05-09 director
LIMIT LIMIT 2023-09-19 director & President & CEO

Henry O Gosebruch Latest Holdings Summary

Henry O Gosebruch currently owns a total of 4 stocks. Among these stocks, Henry O Gosebruch owns 98,580 shares of AbbVie Inc (ABBV) as of May 16, 2022, with a value of $17 Million and a weighting of 72.99%. Henry O Gosebruch owns 524,793 shares of Neumora Therapeutics Inc (NMRA) as of September 19, 2023, with a value of $6 Million and a weighting of 25.69%. Henry O Gosebruch also owns 50,000 shares of Acelyrin Inc (SLRN) as of May 9, 2023, with a value of $294,000 and a weighting of 1.27%. The other 1 stocks Aptinyx Inc (APTX) have a combined weighting of 0.05% among all his current holdings.

Latest Holdings of Henry O Gosebruch

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABBV AbbVie Inc 2022-05-16 98,580 171.09 16,866,052
NMRA Neumora Therapeutics Inc 2023-09-19 524,793 11.31 5,935,409
SLRN Acelyrin Inc 2023-05-09 50,000 5.88 294,000
APTX Aptinyx Inc 2020-01-10 125,000 0.10 12,000

Holding Weightings of Henry O Gosebruch


Henry O Gosebruch Form 4 Trading Tracker

According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 5 transactions in AbbVie Inc (ABBV) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AbbVie Inc is the sale of 83,960 shares on May 16, 2022, which brought Henry O Gosebruch around $13 Million.

According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 1 transactions in Neumora Therapeutics Inc (NMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Neumora Therapeutics Inc is the acquisition of 15,000 shares on September 19, 2023, which cost Henry O Gosebruch around $189,300.

According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 1 transactions in Acelyrin Inc (SLRN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acelyrin Inc is the acquisition of 50,000 shares on May 9, 2023, which cost Henry O Gosebruch around $900,000.

More details on Henry O Gosebruch's insider transactions can be found in the Insider Trading History of Henry O Gosebruch table.

Insider Trading History of Henry O Gosebruch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Henry O Gosebruch Trading Performance

GuruFocus tracks the stock performance after each of Henry O Gosebruch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry O Gosebruch is 1.48%. GuruFocus also compares Henry O Gosebruch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry O Gosebruch within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Henry O Gosebruch's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Henry O Gosebruch

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.12 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.1 LIMIT LIMIT LIMIT LIMIT LIMIT

Henry O Gosebruch Ownership Network

Ownership Network List of Henry O Gosebruch

No Data

Ownership Network Relation of Henry O Gosebruch

Insider Network Chart

Henry O Gosebruch Owned Company Details

What does Aptinyx Inc do?

Who are the key executives at Aptinyx Inc?

Henry O Gosebruch is the director of Aptinyx Inc. Other key executives at Aptinyx Inc include director & CEO and President Norbert G Riedel , CFO and CBO Ashish Khanna , and 10 percent owner Bain Capital Life Sciences Investors, Llc .

Aptinyx Inc (APTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc (APTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc (APTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aptinyx Inc (APTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aptinyx Inc Insider Transactions

No Available Data

Henry O Gosebruch Mailing Address

Above is the net worth, insider trading, and ownership report for Henry O Gosebruch. You might contact Henry O Gosebruch via mailing address: 1 N. Waukegan Road, North Chicago Il 60064-6092.